Form 4: Aclaris Therapeutics Director Leonard Michael Leonard Increases Stake in Company

Director Leonard Michael Leonard reports purchasing additional shares of Aclaris Therapeutics, Inc. (ACRS) common stock through BML Investment Partners, L.P.

Summary

• On June 11, 2024, Leonard Michael Leonard purchased 1,000,000 shares of Aclaris Therapeutics (ACRS) common stock at $1.08 per share.
• On June 12, 2024, he purchased 82,579 shares at a weighted average price of $1.14 per share.
• On June 13, 2024, he made two purchases: 28,621 shares at a weighted average price of $1.1445 per share and 500,000 shares at $1.15 per share.
• These purchases were made indirectly through BML Investment Partners, L.P., where BML Capital Management, LLC serves as the general partner and Mr. Leonard is the managing member.
• Following these transactions, Mr. Leonard's indirect beneficial ownership totals 11,007,134 shares.

Sentiment

Score: 7

Explanation: Insider buying is generally viewed as a positive signal, suggesting confidence in the company's prospects. The size of the purchase is significant, further boosting the sentiment.

Positives

• The director's purchase of shares could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often viewed as a positive sign for a company, suggesting that those with the most knowledge of the company's prospects are optimistic about its future. However, it's important to consider the context of the purchases, such as the size of the purchases relative to the insider's existing holdings and the company's overall financial performance.

Stakeholder Impact

• The increased stake by a director could improve investor confidence.

Key Dates